Furthermore, PD-1 inhibitors have been observed to elicit cutaneous reactions characterized by gene expression profiles that resemble those of SJS and TEN, yet they differ from the profiles associated with acute skin graft-versus-host disease or maculopapular rash. The gene discussed is PDCD1; the disease is Schwartz-Jampel syndrome.